BH3 peptides and method of use thereof

Details BH3 peptides and method of use thereof BH3 peptides and method of use thereof

2011-01-11

2011-01-11

Yu, Misook (Department: 1642)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C514S002600, C424S184100

Reexamination Certificate

active

07868133

ABSTRACT:
The invention provides peptides and the nucleic acid sequences that encode them. The invention further provides therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of apoptosis associated disorders.

REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4676980 (1987-06-01), Segal et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5225539 (1993-07-01), Winter
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5916771 (1999-06-01), Hori et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 5965703 (1999-10-01), Horne et al.
patent: 2002/0115613 (2002-08-01), Kumar
patent: 2004/0171809 (2004-09-01), Korsmeyer et al.
patent: WO 91/00360 (1991-01-01), None
patent: WO 92/20373 (1992-11-01), None
patent: WO 93/08829 (1993-05-01), None
patent: WO 94/02602 (1994-02-01), None
patent: WO 94/11026 (1994-05-01), None
patent: WO 96/27011 (1996-09-01), None
patent: WO 96/33735 (1996-10-01), None
patent: WO 96/34096 (1996-10-01), None
patent: WO 99/53049 (1999-10-01), None
patent: WO 00/59526 (2000-10-01), None
patent: WO 01/12661 (2001-02-01), None
patent: WO 02/20568 (2002-03-01), None
Oda et al , Science, vol. 288, p. 1053-1058, 2000.
Matsushita et al , J Neuroscience, vol. 21, p. 6000-7, 2001.
Sequence search result.
Adams, et al.,Science, 281(5381):1322-1326 (1998).
Boyd, et al.,Oncogene, 11(9):1921-1928 (1995).
Cheng, et al.,Mol. Cell, 8(3):705-711 (2001).
Chittenden, et al.,EMBO J., 14(22):5589-5596 (1995).
Cosulich, et al.,Curr. Biol., 7(12):913-920 (1997).
Ellerby, et al.,Nat. Med., 5(9):1032-1038 (1999).
Eskes, et al.,Mol. Cell. Biol., 20(3):929-935 (2000).
Griffiths, et al.,J. Cell Biol., 144(5):903-914 (1999).
Gross, et al.,EMBO J., 17(14):3878-3885 (1998).
Holinger, et al,J. Biol. Chem., 274(19):13298-13304 (1999).
Kelekar, et al.,Trends in Cell Biol., 8:324-330 (1998).
La Vieira, et al.,Oncogene, 21(13):1963-1977 (2002).
Li, et al.,Cell, 94(4):491-501 (1998).
Li, et al.,Nature, 412:95-99 (2001).
Luo, et al.,Cell, 94(4):481-490 (1998).
Later, et al.,BMC Cell Biology, 2:22 (2001).
Matsuzaki, K.,Biochem. Soc. Transactions, 29:598-601 (2001).
Narita, et al.,Proc. Natl. Acad. Sci. USA, 95:14681-14686 (1998).
O'Connor, et al.,EMBO J., 17(2):384-395 (1998).
Oda, et al.,Science, 288(5468):1053-1058 (2000).
Polster, et al.,J. Biol. Chem., 276(41):37887-37894 (2001).
Putcha, et al.,Neuron, 29(3):615-628 (2001).
Rothbard, et al.,Nat. Med., 6(11):1253-1257 (2000).
Sattler, et al.,Science, 275:983-986 (1997).
Schimmer, et al.,Cell Death and Differentiation, 8(7):725-733 (2001).
Terradillos, et al.,FEBS Lett., 522(1-3):29-34 (2002).
Wang, et al.,Genes&Development, 10(22):2859-2869 (1996).
Wang, et al.,Cancer Res., 60:1498-1502 (2000).
Wei, et al.,Genes&Development, 14:2060-2071 (2000).
Wei, et al.,Science, 292(5517):727-730 (2001).
Westerhoff, et al.,Proc. Natl. Acad. Sci. USA, 86(17):6597-6601 (1989).
Wolter, et al.,J. Cell Biol., 139(5):1281-1292 (1997).
Yang, et al.,Cell, 80(2):285-291 (1995).
Yang, et al.,Methods Enzymol., 130:208-269 (1986).
Zha, et al.,J. Biol. Chem., 272(39):24101-24104 (1997).
Zha, et al.,Science, 290(5497)1761-1765 (2000).
Zong, et al.,Genes&Development, 15:1481-1486 (2001).
Aït-Ikhlef et al.Neurosci. Lett., 199:163-166 (1995).
International Search Report for PCT/US03/28482, mailed Dec. 8, 2005.
Werner et al., “Bcl-2 Family Member Bfl-1/A1 Sequesters Truncated Bid to Inhibit its Collaboration With Pro-Apoptotic Bak or Bax”.J. Biol. Chem.,277(25):22781-22788 (2002).
Supplementary Partial European Search Report for EP 03 74 9602, mailed Sep. 28, 2006.
Brady et al., “Reflections on a peptide”Nature, 368:692-693 (1994).
Brennan et al., “Preparation of Bispecific Antibodies by Chemical Recombination of Monoclonal Immunoglobulin G1Fragments”Science, 229:81 (1985).
Caron et al., “Engineered Humanized Dimeric Forms of IgG Are More Effective Antibiotics”,J. Exp. Med., 176:1191-1195 (1992).
Cole et al., “The EBV-Hybridoma technique and its application to human lung cancer”,Monoclonal Antibodies and Cancer Therapy, 77-96 (1985).
Cote et al., “Generation of human monoclonal antibiotics reactive with cellular antigens”,Proc. Natl. Acad. Sci. USA, 80:2026-2030 (1983).
DeGrado, “Designs of peptides and proteins”,Adv Protein Chem, 39:51-124 (1988).
Fishwild et al., “High-avidity human IgGk monoclonal antibodies from a novel strain of minilocus transgenic mice”,Nature Biotechnology, 14:845-851 (1996).
Futaki et al., “Arginine-rich Peptides: An Abundant Source of Membrane-Permeable Peptides Having Potential as Carriers for Intracellular Protein Delivery”,J. Biol. Chem., 276(8):5836-5840(2001).
Grosschedl et al., “Introduction of a μ immunoglobulin gene into the mouse germ line: specific expression in lymphoid cells and synthesis of functional antibody”,Cell, 38:647-658 (1984).
Gruber et al., “Efficient Tumor Cell Lysis Mediated by a Bispecific Single Chain Antibody Expressed inEscherichia coli”, J. Immunol., 152:5368-5374 (1994).
Hanahan et al., “Heritable formation of pancreatic β-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes”,Nature, 315:115-122 (1985).
Hengartner et al., “C. elegansCell Survival Gene ced-9 Encodes a functional Homolog of the Mammalian Proto-Oncogene bcl-2”,Cell, 76:665-676 (1994).
Hollinger et al., “Diabodies: Small bivalent and bispecific antibody fragments”Proc. Natl. Acad. Sci. USA, 90:6444-6448 (1993).
Hoogenboom et al., “By-passing Immunisation, Human Antibodies from Synthetic Repertoires of Germline VHGene segments rearranged in Vitro”J. Mol. Biol., 227:381-388 (1992).
Hopp et al., “Prediction of protein antigenic determinants from amino acid sequences”Proc. Natl. Acad. Sci. USA, 78:3824-3828 (1981).
Huse et al., “Generation of a large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda”Science, 246:1275-1281 (1989).
Jameson et al., “A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis”,Nature, 368:744-746 (1994).
Jones et al.,Nature, “Replacing the complementarily- determining regions in a human antibody with those from a mouse”, 321:522-525 (1986).
Kohler et al., “Continuous cultures of fused cells secreting anti-body of predefined specificity”,Nature, 256:495-497 (1975).
Kostelny et al., “Formation of a Bispecific antibody by the Leucine Zippers”,J. Immunol., 148(5):1547-1553 (1992).
Kozbor et al., “The production of monoclonal antibodies from human lymphocytes”,Immunol Today, 4:72-79 (1983).
Kozbor, “A human hybrid Myeloma for production of human monoclonal antibodies”,J. Immunol., 133:3001-3005 (1984).
Krieg, “Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides”,Biochim Biophys Acta, 1489(1):107-116 (1999).
Kyte et al., “A Simple Method for displaying the Hydropathic Character of a protein”,J. Mol. Biol., 157:105-142 (1982).
Li et al., “tsg 101: A novel tumor susceptibility gene isolated by controlled Homozygous functional knockout of Allelic Loci in Mammalian Cells”,Cell, 85:319-329 (1996).
Lonberg et al., “Antigen-specific human antibodies from mice comprising four distinct genetic modifications”,Nature, 368:856-859 (1994).
Lonberg et al., “Human Antibodies from Transgenic Mice”,Intern. Rev. Immunol., 13:65-93 (1995).
Luo et al., Bid, a Bc12 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors,Cell, 94(4):481-490 (1998)

Affiliated with

Also associated with

Rating

BH3 peptides and method of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with BH3 peptides and method of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BH3 peptides and method of use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2716224